Bharat Immunologicals & Biologicals Corporation Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 144.647 million compared to INR 185.712 million a year ago. Net income was INR 19.264 million compared to net loss of INR 7.845 million a year ago. Basic earnings per share from continuing operations was INR 0.45 compared to basic loss per share from continuing operations of INR 0.18 a year ago.